277 related articles for article (PubMed ID: 30145943)
1. Stereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-Analysis.
Jingu K; Matsushita H; Yamamoto T; Umezawa R; Ishikawa Y; Takahashi N; Katagiri Y; Takeda K; Kadoya N
Technol Cancer Res Treat; 2018 Jan; 17():1533033818794936. PubMed ID: 30145943
[TBL] [Abstract][Full Text] [Related]
2. Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma.
Yamamoto T; Niibe Y; Matsumoto Y; Onishi H; Aoki M; Nishikawa A; Oh RJ; Shintani T; Yahara K; Ozaki M; Manabe Y; Jingu K
J Radiat Res; 2020 Nov; 61(6):935-944. PubMed ID: 32940330
[TBL] [Abstract][Full Text] [Related]
3. Dose Escalation Improves Outcome in Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer.
Jingu K; Matsuo Y; Onishi H; Yamamoto T; Aoki M; Murakami Y; Yamashita H; Kakuhara H; Nemoto K; Sakayauchi T; Okamoto M; Niibe Y; Nagata Y; Ogawa K
Anticancer Res; 2017 May; 37(5):2709-2713. PubMed ID: 28476849
[TBL] [Abstract][Full Text] [Related]
4. Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer.
Takeda A; Sanuki N; Kunieda E
World J Gastroenterol; 2014 Apr; 20(15):4220-9. PubMed ID: 24764660
[TBL] [Abstract][Full Text] [Related]
5. Tumor Control and Overall Survival after Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer: A Meta-Analysis.
Choi HS; Jeong BK; Kang KM; Jeong H; Song JH; Ha IB; Kwon OY
Cancer Res Treat; 2020 Oct; 52(4):1188-1198. PubMed ID: 32718145
[TBL] [Abstract][Full Text] [Related]
6. [Role of stereotactic radiotherapy in the treatment of oligometastatic colorectal cancer].
Pouypoudat C; Trouette R; Bernard B; Vendrely V
Cancer Radiother; 2021 Oct; 25(6-7):523-525. PubMed ID: 34454836
[TBL] [Abstract][Full Text] [Related]
7. Survival and prognostic factors of pulmonary oligometastases treated with stereotactic body radiotherapy.
Sharma A; Duijm M; Oomen-de Hoop E; Aerts JG; Verhoef C; Hoogeman M; Nuyttens JJ
Acta Oncol; 2019 Jan; 58(1):74-80. PubMed ID: 30280633
[TBL] [Abstract][Full Text] [Related]
8. Outcomes after hypofractionated stereotactic radiotherapy for colorectal cancer oligometastases.
Yu J; Li N; Tang Y; Wang X; Tang Y; Wang SL; Song YW; Liu YP; Li YX; Jin J
J Surg Oncol; 2019 Mar; 119(4):532-538. PubMed ID: 30609038
[TBL] [Abstract][Full Text] [Related]
9. Analyses of the local control of pulmonary Oligometastases after stereotactic body radiotherapy and the impact of local control on survival.
Yamamoto T; Niibe Y; Aoki M; Shintani T; Yamada K; Kobayashi M; Yamashita H; Ozaki M; Manabe Y; Onishi H; Yahara K; Nishikawa A; Katsui K; Oh RJ; Terahara A; Jingu K
BMC Cancer; 2020 Oct; 20(1):997. PubMed ID: 33054721
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors for local control in primary and metastatic lung tumours after four to five fraction stereotactic ablative body radiotherapy: a single institution's comprehensive experience.
Thibault I; Poon I; Yeung L; Erler D; Kim A; Keller B; Lochray F; Jain S; Soliman H; Cheung P
Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):713-9. PubMed ID: 25085765
[TBL] [Abstract][Full Text] [Related]
12. Recursive partitioning model-based analysis for survival of colorectal cancer patients with lung and liver oligometastases treated with stereotactic body radiation therapy.
Franzese C; Comito T; Franceschini D; Loi M; Clerici E; Navarria P; De Rose F; Di Brina L; Mancosu P; Reggiori G; Tomatis S; Scorsetti M
J Cancer Res Clin Oncol; 2020 May; 146(5):1227-1234. PubMed ID: 32056005
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic Body Radiotherapy in Patients with Lung Oligometastases from Colorectal Cancer.
Pasqualetti F; Montrone S; Vivaldi C; Zani M; Fedele D; Fornaro L; Pasqualetti G; Salvatore L; Manfredi B; Laliscia C; Coraggio G; Gonnelli A; Loupakis F; Masi G; Sainato A; Monzani F; Falcone A; Paiar F
Anticancer Res; 2017 Jan; 37(1):315-319. PubMed ID: 28011508
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic Radiotherapy for Oligometastases in Lymph Nodes-A Review.
Matsushita H; Jingu K; Umezawa R; Yamamoto T; Ishikawa Y; Takahashi N; Katagiri Y; Kadoya N
Technol Cancer Res Treat; 2018 Jan; 17():1533033818803597. PubMed ID: 30352542
[TBL] [Abstract][Full Text] [Related]
15. 30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic disease.
Osti MF; Agolli L; Valeriani M; Reverberi C; Bracci S; Marinelli L; De Sanctis V; Cortesi E; Martelli M; De Dominicis C; Minniti G; Nicosia L
Lung Cancer; 2018 Aug; 122():165-170. PubMed ID: 30032826
[TBL] [Abstract][Full Text] [Related]
16. Exploratory Analysis on Overall Survival after Either Surgery or Stereotactic Radiotherapy for Lung Oligometastases from Colorectal Cancer.
Filippi AR; Guerrera F; Badellino S; Ceccarelli M; Castiglione A; Guarneri A; Spadi R; Racca P; Ciccone G; Ricardi U; Ruffini E
Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):505-12. PubMed ID: 26899780
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83-100 Gy in five fractions.
Takeda A; Sanuki N; Tsurugai Y; Oku Y; Aoki Y
J Radiat Res; 2016 Jul; 57(4):400-5. PubMed ID: 26983981
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancer.
Seo YS; Kim MS; Yoo HJ; Jang WI
World J Gastroenterol; 2014 Feb; 20(8):2005-13. PubMed ID: 24587675
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic Body Radiotherapy for Lung Oligo-metastases: Systematic Review and International Stereotactic Radiosurgery Society Practice Guidelines.
Mayinger M; Kotecha R; Sahgal A; Kim MS; Lo SS; Louie AV; Scorsetti M; Slotman B; Guckenberger M
Lung Cancer; 2023 Aug; 182():107284. PubMed ID: 37390723
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting local control of pulmonary oligometastases treated with stereotactic body radiotherapy.
Sharma A; Duijm M; Oomen-de Hoop E; Aerts JG; Verhoef C; Hoogeman M; Nuyttens JJ
Acta Oncol; 2018 Aug; 57(8):1031-1037. PubMed ID: 29488414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
